Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndrome: primary results of the DISPERSE-2 trial.
Saved in:
| Title: | Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndrome: primary results of the DISPERSE-2 trial. |
|---|---|
| Authors: | Cannon CP (AUTHOR), Husted S (AUTHOR), Harrington RA (AUTHOR), Scirica BM (AUTHOR), Emanuelsson H (AUTHOR), Peters G (AUTHOR), Storey RF (AUTHOR), DISPERSE-2 Investigators (CORPORATE AUTHOR) |
| Source: | Journal of the American College of Cardiology (JACC). Nov2007, Vol. 50 Issue 19, p1844-1851. 8p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 105983452 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndrome: primary results of the DISPERSE-2 trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Cannon+CP%22">Cannon CP</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Husted+S%22">Husted S</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Harrington+RA%22">Harrington RA</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Scirica+BM%22">Scirica BM</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Emanuelsson+H%22">Emanuelsson H</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Peters+G%22">Peters G</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Storey+RF%22">Storey RF</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22DISPERSE-2+Investigators%22">DISPERSE-2 Investigators</searchLink> (CORPORATE AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Journal+of+the+American+College+of+Cardiology+%28JACC%29%22">Journal of the American College of Cardiology (JACC)</searchLink>. Nov2007, Vol. 50 Issue 19, p1844-1851. 8p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=105983452 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jacc.2007.07.053 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 8 StartPage: 1844 Titles: – TitleFull: Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndrome: primary results of the DISPERSE-2 trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Cannon CP – PersonEntity: Name: NameFull: Husted S – PersonEntity: Name: NameFull: Harrington RA – PersonEntity: Name: NameFull: Scirica BM – PersonEntity: Name: NameFull: Emanuelsson H – PersonEntity: Name: NameFull: Peters G – PersonEntity: Name: NameFull: Storey RF – PersonEntity: Name: NameFull: DISPERSE-2 Investigators IsPartOfRelationships: – BibEntity: Dates: – D: 06 M: 11 Text: Nov2007 Type: published Y: 2007 Identifiers: – Type: issn-print Value: 07351097 Numbering: – Type: volume Value: 50 – Type: issue Value: 19 Titles: – TitleFull: Journal of the American College of Cardiology (JACC) Type: main |
| ResultId | 1 |
